
The study investigated the association between Galectin-4 (Gal-4) levels and diabetes prevalence in a Swedish heart failure (HF) population. Using data from 324 hospitalized HF patients, Gal-4 was measured, and its associations with diabetes, obesity, and biomarkers were explored. Higher Gal-4 levels were positively linked to prevalent diabetes, especially in HF patients with reduced ejection fraction. Gal-4 also showed a significant association with obesity, particularly in subjects with diabetes. Elevated Gal-4 levels were found in HF patients with diabetes and obesity. Additionally, Gal-4 demonstrated associations with the incretin GIP and biomarkers of HF. This cross-sectional study suggests a multifaceted role for Gal-4 in HF patients.
Like
Save
Share